Prestige Consumer Healthcare PBH Ratios & Valuation
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.7%-1.4pp | 56.1%0.0pp | 56.1%0.0pp | 56.1%+0.4pp | 55.8%+0.7pp | |
| Operating margin | 28.4%-0.8pp | 29.2%-0.7pp | 29.9%-0.2pp | 30%+0.4pp | 29.6%0.0pp | |
| Net margin | 17.5%+0.6pp | 16.9%-1.2pp | 18.1%-0.9pp | 19%+0.2pp | 18.9%-0.3pp | |
| EBITDA margin | 31.3%-0.7pp | 31.9%-0.6pp | 32.5%-0.2pp | 32.7%+0.4pp | 32.3%-0.1pp | |
| Free cash flow margin | 22.6%-1.6pp | 24.2%+1.2pp | 23%-0.9pp | 23.9%+2.5pp | 21.4%-0.9pp | |
| Returns | ||||||
| Return on equity | 10.2%-0.1pp | 10.3%-1.0pp | 11.3%-0.8pp | 12%-0.3pp | 12.3%-0.3pp | |
| Return on assets | 5.5%+0.1pp | 5.5%-0.5pp | 5.9%-0.4pp | 6.3%-0.1pp | 6.4%0.0pp | |
| Return on invested capital | 10.9%-0.5pp | 11.5%-0.6pp | 12.1%-0.1pp | 12.2%0.0pp | 12.2%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Inventory turnover | 3.2×+0.1× | 3.1×0.0× | 3.1×-0.1× | 3.2×-0.3× | 3.5×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.6×+0.5× | 3.1×-0.6× | 3.7×-0.7× | 4.4×+0.2× | 4.2×+0.5× | |
| Quick ratio | 2.3×+0.3× | 1.9×-0.6× | 2.5×-0.5× | 3×+0.2× | 2.8×+0.6× | |
| Cash ratio | 0.5×+0.1× | 0.4×-0.4× | 0.9×-0.4× | 1.3×+0.4× | 0.9×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 2.9×0.0× | 2.9×+0.3× | 2.6×+0.1× | 2.5×-0.1× | 2.6×-0.1× | |
| Per Share | ||||||
| Book value per share | $38.74+1.8% | $38.04+2.7% | $37.04-0.5% | $37.23+1.6% | $36.64+2.4% | |
| Valuation | ||||||
| Market capitalization | $2.8B-5.5% | $2.97B-3.4% | $3.07B-26.3% | $4.17B-2.1% | $4.26B+10.4% | |
| Enterprise value | $3.79B-5.0% | $3.99B-0.2% | $4B-21.3% | $5.07B-2.6% | $5.21B+7.5% | |
| Price / earnings | 14.7×-1.2× | 15.9×+0.6× | 15.3×-4.3× | 19.6×-0.3× | 19.8×+1.8× | |
| Price / sales | 2.6×-0.1× | 2.7×-0.1× | 2.8×-1.0× | 3.7×0.0× | 3.7×+0.3× | |
| Price / book | 1.5×-0.1× | 1.6×-0.1× | 1.7×-0.6× | 2.2×-0.1× | 2.3×+0.2× | |
| EV / EBITDA | 11.1×-0.2× | 11.3×+0.2× | 11.1×-2.8× | 13.9×-0.3× | 14.2×+0.8× | |
| EV / sales | 3.5×-0.1× | 3.6×0.0× | 3.6×-0.9× | 4.5×0.0× | 4.6×+0.2× | |
| Free cash flow yield | 8.8%-0.2pp | 9%+0.7pp | 8.3%+1.9pp | 6.4%+0.7pp | 5.7%-0.7pp | |
| Earnings yield | 6.8%+0.5pp | 6.3%-0.3pp | 6.5%+1.4pp | 5.1%+0.1pp | 5%-0.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Prestige Consumer Healthcare's profit margins?
- Prestige Consumer Healthcare (PBH) runs a 54.7% gross margin and a 28.4% operating margin, with a 17.5% net margin.
- Where do Prestige Consumer Healthcare's ratios come from?
- Every ratio is computed from Prestige Consumer Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.